ALERCELL, Inc is a brand new life science company focused on research in the areas of cancer, leukemia, and infectious diseases. They have a steady revenue stream from medical supplies as research progresses. The company's CEO has a deep understanding of the patent world with 15 biotechnology patents. Research is being conducted in a market estimated at $500 billion.